Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 6.255\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) CCC1(C)NC(=O)N(NC(=O)C(C)Oc2ccc(C(C)(C)C)cc2)C1=O
b) COc1ccc(NC(=O)CNC(=O)c2sc3ccccc3c2Cl)c(OC)c1
Answer: a. CCC1(C)NC(=O)N(NC(=O)C(C)Oc2ccc(C(C)(C)C)cc2)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC1(C)NC(=O)N(NC(=O)C(C)Oc2ccc(C(C)(C)C)cc2)C1=O
CCC1(C)NC(=O)N(NC(=O)C(C)Oc2ccc(C(C)(C)C)cc2)C1=O
2-(4-tert-butylphenoxy)-N-(4-ethyl-4-methyl-2,5-dioxoimidazolidin-1-yl)propanamide